In a world where hormonal health is no longer an afterthought but a cornerstone of modern medicine, the combined pituitary hormone deficiencies (CPHD) market is undergoing a seismic shift. The global combined pituitary hormone deficiencies market size was valued at USD 2.03 billion in 2024 and is expected to reach USD 2.94 billion by 2032, at a CAGR of...